Low-Intensity Pulsed Ultrasound Enhances Neurotrophic Factors and Alleviates Neuroinflammation in a Rat Model of Parkinson’s Disease
Authors:
- 1 July 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Cerebral Cortex
- Vol. 32 (1) , 176-185
Abstract
Low-intensity pulsed ultrasound (LIPUS) has also been reported to improve behavioral functions in Parkinson’s disease (PD) animal models; however, the effect of LIPUS stimulation on the neurotrophic factors and neuroinflammation has not yet been addressed. PD rat model was built by injection of 6-hydroxydopamine (6-OHDA) in 2 sites in the right striatum. The levels of neurotrophic factors and lipocalin-2 (LCN2)-induced neuroinflammation were quantified using a western blot. Rotational test and cylinder test were conducted biweekly for 8 weeks. When the 6-OHDA + LIPUS and 6-OHDA groups were compared, the locomotor function of the 6-OHDA + LIPUS rats was significantly improved. After LIPUS stimulation, the tyrosine hydroxylase staining density was significantly increased in the striatum and substantia nigra pars compacta (SNpc) of lesioned rats. Unilateral LIPUS stimulation did not increase brain-derived neurotrophic factor in the striatum and SNpc of lesioned rats. In contrast, unilateral LIPUS stimulation increased glial cell line-derived neurotrophic factor (GDNF) protein 1.98-fold unilaterally in the SNpc. Additionally, LCN2-induced neuroinflammation can be attenuated following LIPUS stimulation. Our data indicated that LIPUS stimulation may be a potential therapeutic tool against PD via enhancement of GDNF level and inhibition of inflammatory responses in the SNpc of the brain.Keywords
Funding Information
- Ministry of Science and Technology of Taiwan (MOST 109-2321-B-010-004, MOST 108-2314-B-010-034-MY3, MOST 106-2221-E-010-004-MY3)
- Cheng Hsin General Hospital Foundation (CY11006, CY10927, CY10833)
This publication has 46 references indexed in Scilit:
- Targeted Delivery of GDNF through the Blood–Brain Barrier by MRI-Guided Focused UltrasoundPLOS ONE, 2012
- Therapies in Parkinsonʼs diseaseCurrent Opinion in Neurology, 2012
- Neurotoxin-induced ER stress in mouse dopaminergic neurons involves downregulation of TRPC1 and inhibition of AKT/mTOR signalingJournal of Clinical Investigation, 2012
- In vivo magnetic resonance imaging characterization of bilateral structural changes in experimental Parkinson’s disease: a T2 relaxometry study combined with longitudinal diffusion tensor imaging and manganese-enhanced magnetic resonance imaging in the 6-European Journal of Neuroscience, 2011
- Peroxiredoxin-2 Protects against 6-Hydroxydopamine-Induced Dopaminergic Neurodegeneration via Attenuation of the Apoptosis Signal-Regulating Kinase (ASK1) Signaling CascadeJournal of Neuroscience, 2011
- Noninvasive Brain Stimulation for Parkinson’s Disease and DystoniaNeurotherapeutics, 2008
- Neutrophil Gelatinase-associated Lipocalin, a Siderophore-binding Eukaryotic ProteinBioMetals, 2006
- Repetitive transcranial magnetic stimulation has a beneficial effect on bradykinesia in Parkinsonʼs diseaseNeuroReport, 1999
- Functional recovery in parkinsonian monkeys treated with GDNFNature, 1996
- GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic NeuronsScience, 1993